MedTrace Logo

Prostaglandin E2 in Migraine Suffers Without Aura.

NCT01384812 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2011-11-09

No results posted yet for this study

Summary

The hypothesis of this study is that Prostaglandin E2 (PGE2) induces headache and dilatation of brain vessels in migraine patients without aura.

Conditions

  • "Migraine-like" Headache

Interventions

DRUG

dinoprostone

intravenous injection 0.4 μgr/kg/min for 25 min

DRUG

isoton sodium chloride

intravenous injection for 25 min

Sponsors & Collaborators

  • Troels Wienecke

    lead OTHER

Principal Investigators

  • Troels Wienecke, MD,PhD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01384812 on ClinicalTrials.gov